Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Nagler, A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 321 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Nagler, A; Menachem, Y; Ilan, Y
      Amelioration of steroid-resistant chronic graft-versus-host-mediated liverdisease via tacrolimus treatment

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    2. Slavin, S; Nagler, A; Shapira, M; Panigrahi, S; Samuel, S; Or, A
      Non-myeloablative allogeneic stem cell transplantation focusing on immunotherapy of life-threatening malignant and non-malignant diseases

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    3. Bauer, R; Begerow, D; Nagler, A; Oberwinkler, F
      The Georgefischeriales: a phylogenetic hypothesis

      MYCOLOGICAL RESEARCH
    4. Shalit, I; Kletter, Y; Halperin, D; Waldman, D; Vasserman, E; Nagler, A; Fabian, I
      Immunomodulatory effects of moxifloxacin in comparison to ciprofloxacin and G-CSF in a murine model of cyclophosphamide-induced leukopenia

      EUROPEAN JOURNAL OF HAEMATOLOGY
    5. Sweetenham, JW; Santini, G; Qian, W; Guelfi, M; Schmitz, N; Simnett, S; Nagler, A; Holte, H; Kvaloy, S; Bruzzi, P; Goldstone, AH
      High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: Results of a randomized trial of the European group for blood and marrow transplantation and the United Kingdom lymphoma group

      JOURNAL OF CLINICAL ONCOLOGY
    6. Slavin, S; Or, R; Aker, M; Shapira, MY; Panigrahi, S; Symeonidis, A; Cividalli, G; Nagler, A
      Nonmyeloablative stem cell transplantation for the treatment of cancer andlife-threatening nonmalignant disorders: past accomplishments and future goals

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    7. Nagler, A; Aker, M; Or, R; Naparstek, E; Varadi, G; Brautbar, C; Slavin, S
      Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation

      EXPERIMENTAL HEMATOLOGY
    8. Condiotti, R; Zakai, YB; Barak, V; Nagler, A
      Ex vivo expansion of CD56(+) cytotoxic cells from human umbilical cord blood

      EXPERIMENTAL HEMATOLOGY
    9. Bruck, R; Genina, O; Aeed, H; Alexiev, R; Nagler, A; Avni, Y; Pines, M
      Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats

      HEPATOLOGY
    10. Morecki, S; Gelfand, Y; Nagler, A; Or, R; Naparstek, E; Varadi, G; Engelhard, D; Akerstein, A; Slavin, S
      Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen

      BONE MARROW TRANSPLANTATION
    11. Panigrahi, S; Nagler, A; Or, R; Wolf, DG; Slavin, S; Shapira, MY
      Indolent aspergillus arthritis complicating fludarabine-based non-myeloablative stem cell transplantation

      BONE MARROW TRANSPLANTATION
    12. Safadi, R; Or, R; Ilan, Y; Naparstek, E; Nagler, A; Klein, A; Ketzinel-Gilaad, M; Ergunay, K; Danon, D; Shouval, D; Galun, E
      Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation

      BONE MARROW TRANSPLANTATION
    13. Nagler, RM; Eichen, Y; Nagler, A
      Redox metal chelation ameliorates radiation-induced bone marrow toxicity in a mouse model

      RADIATION RESEARCH
    14. Patlas, M; Shapira, MY; Nagler, A; Sheffer, R; Gomori, JM
      MRI of mannosidosis

      NEURORADIOLOGY
    15. Kollet, O; Spiegel, A; Peled, A; Petit, I; Byk, T; Hershkoviz, R; Guetta, E; Barkai, G; Nagler, A; Lapidot, T
      Rapid and efficient homing of human CD34(+)CD38(-/low)CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2m(null) mice

      BLOOD
    16. Pines, M; Domb, A; Ohana, M; Inbar, J; Genina, O; Alexiev, R; Nagler, A
      Reduction in dermal fibrosis in the tight-skin (Tsk) mouse after local application of halofuginone

      BIOCHEMICAL PHARMACOLOGY
    17. Nagler, RM; Nagler, A
      The effect of pilocarpine on salivary constituents in patients with chronic graft-versus-host disease

      ARCHIVES OF ORAL BIOLOGY
    18. Kolker, O; Sviri, S; Linton, DM; Or, R; Nagler, A; Shapira, MY
      Plasmapheresis for thrombotic thrombocytopenic purpura following bone marrow transplantation

      ACTA HAEMATOLOGICA
    19. Slavin, S; Nagler, A; Panigrahi, S; Varadi, G; Ackerstein, A; Samuel, S; Or, R
      Shifting towards better immunotherapy rather than more intensive chemoradiotherapy using a non-myeloablative approach in patients with leukemia

      ACUTE LEUKEMIAS VIII: PROGNOSTIC FACTORS AND TREATMENT STRATEGIES
    20. Nagler, A; Rabinowitz, R; Rosengolts-Rat, J; Condiotti, R; Schlesinger, M
      Natural killer (NK) and T cell-associated surface marker expression following allogeneic and autologous bone marrow transplantation (BMT)

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    21. Kapelushnik, J; Mandel, H; Varadi, G; Nagler, A
      Fludarabine-based protocol for haploidentical peripheral blood stem cell transplantation in Hurler syndrome

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    22. Elkin, M; Miao, HQ; Nagler, A; Aingorn, E; Reich, R; Hemo, I; Dou, HL; Pines, M; Vlodavsky, I
      Halofuginone: a potent inhibitor of critical steps in angiogenesis progression

      FASEB JOURNAL
    23. Nagler, A; Or, R; Naparstek, E; Varadi, G; Slavin, S
      Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantation

      EXPERIMENTAL HEMATOLOGY
    24. Slavin, S; Nagler, A; Varadi, G; Or, R
      Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis

      EXPERIMENTAL HEMATOLOGY
    25. Kollet, O; Moore, JG; Aviram, R; Ben-Hur, H; Liu, BL; Nagler, A; Shultz, L; Feldman, M; Lapidot, T
      The plant lectin FRIL supports prolonged in vitro maintenance of quiescenthuman cord blood CD34(+)CD38(-/low)/SCID repopulating stem cells

      EXPERIMENTAL HEMATOLOGY
    26. Nagler, A; Ackerstein, A; Or, R; Naparstek, E; Slavin, S
      Adoptive immunotherapy with haploidentical allogeneic peripheral blood lymphocytes following autologous bone marrow transplantation

      EXPERIMENTAL HEMATOLOGY
    27. Pines, M; Vlodavsky, I; Nagler, A
      Halofuginone: From veterinary use to human therapy

      DRUG DEVELOPMENT RESEARCH
    28. Nagler, A; Pines, M; Abadi, U; Pappo, O; Zeira, M; Rabbani, E; Engelhardt, D; Ohana, M; Chowdhury, NR; Chowdhury, JR; Ilan, Y
      Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice

      HEPATOLOGY
    29. Ilan, Y; Nagler, A; Zeira, E; Adler, R; Slavin, S; Shouval, D
      Maintenance of immune memory to the hepatitis B envelope protein followingadoptive transfer of immunity in bone marrow transplant recipients

      BONE MARROW TRANSPLANTATION
    30. Nagler, A; Slavin, S; Varadi, G; Naparstek, E; Samuel, S; Or, R
      Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma

      BONE MARROW TRANSPLANTATION
    31. Levy, S; Nagler, A; Okon, S; Marmary, Y
      Parotid salivary gland dysfunction in chronic graft-versus-host disease (cGVHD): a longitudinal study in a mouse model

      BONE MARROW TRANSPLANTATION
    32. Slavin, S; Or, R; Prighozina, T; Gurevitch, O; Aker, M; Panighari, S; Shapira, M; Nagler, A
      Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals and man

      BONE MARROW TRANSPLANTATION
    33. Nagler, RM; Barak, V; Nagler, A
      Short term systemic effects of head and neck irradiation

      ANTICANCER RESEARCH
    34. Tsafrir, A; Brautbar, C; Nagler, A; Elchalal, U; Miller, K; Bishara, A
      Alloreactivity of umbilical cord blood mononuclear cells: Specific hyporesponse to noninherited maternal antigens

      HUMAN IMMUNOLOGY
    35. Toren, A; Nagler, A; Rozenfeld-Granot, G; Levanon, M; Davidson, J; Bielorai, B; Kaplinsky, C; Meitar, D; Mandel, M; Ackerstein, A; Ballin, A; Attias, D; Biniaminov, M; Rosenthal, E; Brok-Simoni, F; Rechavi, G; Kaufmann, Y
      Amplification of immunological functions by subcutaneous injection of intermediate-high dose interleukin-2 for 2 years after autologous stem cell transplantation in children with stage IV neuroblastoma

      TRANSPLANTATION
    36. Nagler, A; Gofrit, O; Ohana, M; Pode, D; Genina, O; Pines, M
      The effect of halofuginone, an inhibitor of collagen type I synthesis, on urethral stricture formation: In vivo and in vitro study in a rat model

      JOURNAL OF UROLOGY
    37. Ponomaryov, T; Peled, A; Petit, I; Taichman, RS; Habler, L; Sandbank, J; Arenzana-Seisdedos, F; Magerus, A; Caruz, A; Fujii, N; Nagler, A; Lahav, M; Szyper-Kravitz, M; Zipori, D; Lapidot, T
      Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function

      JOURNAL OF CLINICAL INVESTIGATION
    38. Peled, A; Kollet, O; Ponomaryov, T; Petit, I; Franitza, S; Grabovsky, V; Slav, MM; Nagler, A; Lider, O; Alon, R; Zipori, D; Lapidot, T
      The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice

      BLOOD
    39. Ilan, Y; Gotsman, I; Pines, M; Beinart, R; Zeira, M; Ohana, M; Rabbani, E; Engelhardt, D; Nagler, A
      Induction of oral tolerance in splenocyte recipients toward pretransplant antigens ameliorates chronic graft versus host disease in a murine model

      BLOOD
    40. Nagler, RM; Reznick, AZ; Slavin, S; Nagler, A
      Partial protection of rat parotid glands from irradiation-induced hyposalivation by manganese superoxide dismutase

      ARCHIVES OF ORAL BIOLOGY
    41. Elchalal, U; Nagler, A
      Umbilical cord blood collection for transplantation: Which technique should be preferred? Reply

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    42. Elchalal, U; Fasouliotis, SJ; Shtockheim, D; Brautbar, C; Schenker, JG; Weinstein, D; Nagler, A
      Postpartum umbilical cord blood collection for transplantation: A comparison of three methods

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    43. Slavin, S; Morecki, S; Naparstek, E; Nagler, A; Varadi, G; Ben-Yosef, R; Or, R
      Adoptive allogeneic cell-mediated immunotherapy and nonmyeloablative stem-cell transplantation

      ALLOGENEIC IMMUNOTHERAPY FOR MALIGNANT DISEASES
    44. Nagler, RM; Nagler, A
      Major salivary gland involvement in graft-versus-host disease: considerations related to pathogenesis, the role of cytokines and therapy

      CYTOKINES CELLULAR & MOLECULAR THERAPY
    45. Nagler, A; Condiotti, R; Rabinowitz, R; Schlesinger, M; Nguyen, M; Terstappen, LWMM
      Detection of minimal residual disease (MRD) after bone marrow transplantation (BMT) by multi-parameter flow cytometry (MPFC)

      MEDICAL ONCOLOGY
    46. Elkin, M; Reich, R; Nagler, A; Aingorn, E; Pines, M; de-Groot, N; Hochberg, A; Vlodavsky, I
      Inhibition of matrix metalloproteinase-2 expression and bladder carcinoma metastasis by halofuginone

      CLINICAL CANCER RESEARCH
    47. Aker, M; Varadi, G; Slavin, S; Nagler, A
      Fludarabine-based protocol for human umbilical cord blood transplantation in children with fanconi anemia

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    48. Varadi, G; Or, R; Kapelushnik, J; Naparstek, E; Nagler, A; Brautbar, C; Amar, A; Kirschbaum, M; Samuel, S; Slavin, S; Siegal, T
      Graft-versus-lymphoma effect after allogeneic peripheral blood stem cell transplantation for primary central nervous system lymphoma

      LEUKEMIA & LYMPHOMA
    49. Baraz, L; Kotler, M; Condiotti, R; Nagler, A
      Sensitization of resting T cells to autologous natural-killer-cell-mediated lysis by phytohemagglutinin

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    50. Naparstek, E; Delukina, M; Or, R; Nagler, A; Kapelushnik, J; Varadi, G; Strauss, N; Cividalli, G; Aker, M; Brautbar, C; Waldmann, H; Hale, G; Slavin, S
      Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies

      EXPERIMENTAL HEMATOLOGY
    51. Globerson, A; Kollet, O; Abel, L; Fajerman, I; Ballin, A; Nagler, A; Slavin, S; Ben Hur, H; Hagay, Z; Sharp, A; Lapidot, T
      Differential effects of CD4(+) and CD8(+) cells on lymphocyte development from human cord blood cells in murine fetal thymus explants

      EXPERIMENTAL HEMATOLOGY
    52. Nagler, A; Ackerstein, A; Kapelushnik, J; Or, R; Naparstek, E; Slavin, S
      Donor lymphocyte infusion post-non-myeloablative allogeneic peripheral blood stem cell transplantation for chronic granulomatous disease

      BONE MARROW TRANSPLANTATION
    53. Baraz, L; Khazanov, E; Condiotti, R; Kotler, M; Nagler, A
      Natural killer (NK) cells prevent virus production in cell culture

      BONE MARROW TRANSPLANTATION
    54. Rosales, F; Peylan-Ramu, N; Cividalli, G; Varadi, G; Or, R; Naparstek, E; Slavin, S; Nagler, A
      The role of thiotepa in allogeneic bone marrow transplantation for geneticdiseases

      BONE MARROW TRANSPLANTATION
    55. Toren, A; Nagler, A; Amariglio, N; Neumann, Y; Golan, H; Bilori, B; Kaplinsky, C; Mandel, M; Biniaminov, M; Levanon, M; Rosenthal, E; Davidson, J; Brok-Simoni, F; Rechavi, G
      Successful human umbilical cord blood stem cell transplantation without conditioning in severe combined immune deficiency

      BONE MARROW TRANSPLANTATION
    56. Nagler, RM; Nagler, A
      Pilocarpine hydrochloride relieves xerostomia in chronic graft-versus-hostdisease: a sialometrical study

      BONE MARROW TRANSPLANTATION
    57. Bishara, A; Brautbar, C; Cohen, I; Nagler, A
      Positivity in a modified mixed leukocyte reaction test correlates with molecular HLA-C disparity in prediction of unrelated bone marrow transplantation outcome

      HUMAN IMMUNOLOGY
    58. Rosales, F; Naparstek, E; Varadi, G; Or, R; Slavin, S; Nagler, A
      The role of thiotepa in allogeneic stem cell transplantation in patients with leukemia

      LEUKEMIA RESEARCH
    59. Nagler, A; Pines, M
      Topical treatment of cutaneous chronic graft versus host disease with halofuginone - A novel inhibitor of collagen type I synthesis

      TRANSPLANTATION
    60. Peled, A; Petit, I; Kollet, O; Magid, M; Ponomaryov, T; Byk, T; Nagler, A; Ben-Hur, H; Many, A; Shultz, L; Lider, O; Alon, R; Zipori, D; Lapidot, T
      Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4

      SCIENCE
    61. Witenberg, B; Kletter, Y; Kalir, HH; Raviv, Z; Fenig, E; Nagler, A; Halperin, D; Fabian, I
      Ascorbic acid inhibits apoptosis induced by X irradiation in HL60 myeloid leukemia cells

      RADIATION RESEARCH
    62. Levi-Schaffer, F; Garbuzenko, E; Rubin, A; Reich, R; Pickholz, D; Gillery, P; Emonard, H; Nagler, A; Maquart, FAX
      Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: A role for transforming growth factor beta (TGF-beta)

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    63. Nagler, RM; Sherman, Y; Nagler, A
      Histopathological study of the human submandibular gland in graft versus host disease (vol 52, pg 395, 1999)

      JOURNAL OF CLINICAL PATHOLOGY
    64. Nagler, RM; Sherman, Y; Nagler, A
      Histopathological study of the human submandibular gland in graft versus host disease

      JOURNAL OF CLINICAL PATHOLOGY
    65. Elkin, M; Ariel, I; Miao, HQ; Nagler, A; Pines, M; de-Groot, N; Hochberg, A; Vlodavsky, I
      Inhibition of bladder carcinoma angiogenesis, stromal support, and tumor growth by halofuginone

      CANCER RESEARCH
    66. Kollet, O; Aviram, R; Chebath, J; ben-Hur, H; Nagler, A; Shultz, L; Revel, M; Lapidot, T
      The soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro maintenance and proliferation of human CD34(+)CD38(-/low) cells capable of repopulating severe combined immunodeficiency mice

      BLOOD
    67. Nagler, A; Genina, O; Lavelin, I; Ohana, M; Pines, M
      Halofuginone, an inhibitor of collagen type I synthesis, prevents postoperative adhesion formation in the rat uterine horn model

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    68. Guberman, D; Gilead, LT; Nagler, A
      Skin calcinosis following allogenic bone marrow transplantation in an acute lymphoblastic leukaemia patient

      ACTA DERMATO-VENEREOLOGICA
    69. OR R; ACKERSTEIN A; NAGLER A; AMAR A; NAPARSTEK E; VARADI G; KAPELUSHNIK J; SAMUEL S; PUGATSCH T; BRAUTBAR C; SLAVIN S
      ALLOGENEIC CELL-MEDIATED AND CYTOKINE-ACTIVATED IMMUNOTHERAPY FOR MALIGNANT-LYMPHOMA AT THE STAGE OF MINIMAL RESIDUAL DISEASE AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION

      Journal of immunotherapy
    70. Toren, A; Rechavi, G; Nagler, A
      Early fulminant leukaemia post autologous bone marrow transplantation in non-Hodgkin's lymphoma patients

      MEDICAL ONCOLOGY
    71. Toren, A; Nagler, R; Nagler, A
      Involved field radiation post autologous stem cell transplantation in lymphoma patients is associated with major haematological toxicities

      MEDICAL ONCOLOGY
    72. KOLLET O; REVEL M; CHEBATH J; NAGLER A; LAPIDOT T
      SOLUBLE IL-6 RECEPTOR IL-6 FUSION PROTEIN ENHANCE MAINTENANCE AND PROLIFERATION OF HUMAN CD34(+) CD38(-/LOW) STEM-CELLS IN-VITRO/

      European cytokine network
    73. BARAK V; CONDIOTTI R; ZAKAI YB; NAGLER A
      CYTOKINE LEVELS IN EX-VIVO EXPANDED CORD BLOOD-DERIVED NATURAL-KILLER(NK) CELLS

      European cytokine network
    74. KAPELUSHNIK J; VARADI G; NAGLER A
      MATCHED UNRELATED HUMAN UMBILICAL-CORD BLOOD TRANSPLANTATION FOR X-LINKED ADRENOLEUKODYSTROPHY

      Journal of pediatric hematology/oncology
    75. AKER M; KAPELUSHNIK J; PUGATSCH T; NAPARSTEK E; BENNERIA S; YEHUDA O; AMAR A; NAGLER A; SLAVIN S; OR R
      DONOR LYMPHOCYTE INFUSIONS TO DISPLACE RESIDUAL HOST HEMATOPOIETIC-CELLS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR BETA-THALASSEMIA MAJOR

      Journal of pediatric hematology/oncology
    76. NAGLER RM; LAUFER D; NAGLER A
      PAROTID-GLAND DYSFUNCTION IN A MURINE MODEL OF ACUTE GRAFT-VERSUS-HOST DISEASE [AGVHD]

      Head & neck
    77. SLAVIN S; NAGLER A
      IMMUNOTHERAPY IN CONJUNCTION WITH AUTOLOGOUS AND ALLOGENEIC BLOOD OR MARROW TRANSPLANTATION IN LYMPHOMA

      Annals of oncology
    78. PINES M; NAGLER A
      HALOFUGINONE - A NOVEL ANTIFIBROTIC THERAPY

      General pharmacology
    79. WITENBERG B; KLETTER Y; KALIR HH; RAVIV Z; FENIG E; NAGLER A; HALPERIN D; FABIAN I
      ASCORBIC-ACID INHIBITS APOPTOSIS INDUCED BY X-IRRADIATION IN HL-60 MYELOID-LEUKEMIA CELLS

      Experimental hematology
    80. CONDIOTTI E; ZAKAI YB; LAPIDOT T; NAGLER A
      EXPANSION OF CORD-BLOOD DERIVED NATURAL-KILLER-CELLS FOR AMPLIFICATION OF THE GRAFT-VERSUS-LEUKEMIA EFFECT

      Experimental hematology
    81. NAGLER A; PINES M; ABADI U; PAPPO O; ZEIRA M; CHOWDHURY NR; CHOWDHURY JR; ILAN Y
      INDUCTION OF ORAL TOLERANCE IN A MURINE MODEL OF CHRONIC GRAFT-VERSUS-HOST DISEASE AMELIORATES DISEASE MANIFESTATION

      Experimental hematology
    82. NAPARSTEK E; NAGLER A; OR R; VARADI G; BENYOSEF R; ACKERSTEIN A; SLAVIN S
      POST TRANSPLANT IMMUNOTHERAPY FOR PREVENTION OF RELAPSE AFTER AUTOLOGOUS BMT FOR ACUTE-LEUKEMIA

      Experimental hematology
    83. SLAVIN S; NAGLER A; NAPARSTEK E; OR R; VARADI G; BENYOSEF R; HUSSIEN A; AKER M; CIVIDALLI G
      LEUKEMIA IMMUNOTHERAPY IN CONJUNCTION WITH NON MYELOABLATIVE ALLOGENEIC STEM-CELL TRANSPLANTATION

      Experimental hematology
    84. DEUTSCH VR; PICK M; IRONY M; ELDOR A; NAGLER A
      SUSTAINED HIGH THROMBOPOIETIN (TPO) LEVELS IN SEVERE APLASTIC-ANEMIA (SAA) PATIENTS MAY FACILITATE PLATELET ENGRAFTMENT FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)

      Experimental hematology
    85. TOREN A; RECHAVI G; NAGLER A
      INVOLVED FIELD RADIATION POST AUTOLOGOUS STEM-CELL TRANSPLANTATION INLYMPHOMA PATIENTS IS ASSOCIATED WITH MAJOR HEMATOLOGICAL TOXICITIES

      Experimental hematology
    86. VARADI G; NAPARSTEK E; SLAVIN OS; SHAPIRO M; NAGLER A
      INVASIVE FUNGAL INFECTION IN PATIENTS UNDERGOING BONE-MARROW TRANSPLANTATION

      Experimental hematology
    87. CONDIOTTI R; NAGLER A
      EFFECT OF INTERLEUKIN-12 ON ANTITUMOR-ACTIVITY OF HUMAN UMBILICAL-CORD BLOOD AND BONE-MARROW CYTOTOXIC-CELLS

      Experimental hematology
    88. NAGLER A; FEFERMAN R; SHOSHAN S
      REDUCTION IN BASIC FIBROBLAST GROWTH-FACTOR MEDIATED ANGIOGENESIS IN-VIVO BY LINOMIDE

      Connective tissue research
    89. NAGLER A; PINES M; ABADI U; PAPPO O; ZEIRA M; ENGELHARDT D; RABANI E; CHOWDHURY NR; CHOWDHURY JR; ILAN Y
      ORAL TOLERIZATION AMELIORATES LIVER DISORDERS ASSOCIATED WITH CHRONICGRAFT-VERSUS-HOST DISEASE

      Hepatology
    90. MINIERO R; ROCHA V; SARACCO P; LOCATELLI F; BRICHARD B; NAGLER A; ROBERTS I; YANIV I; BEKSAC M; BERNAUDIN F; GLUCKMAN E
      CORD-BLOOD TRANSPLANTATION (CBT) IN HEMOGLOBINOPATHIES

      Bone marrow transplantation
    91. SCHMITZ N; BACIGALUPO A; HASENCLEVER D; NAGLER A; GLUCKMAN E; CLARK P; BOURQUELOT P; GREINIX H; FRICKHOFEN N; RINGDEN O; ZANDER A; APPERLEY JF; GORIN C; BORKETT K; SCHWAB G; GOEBEL M; RUSSELL NH; GRATWOHL A
      ALLOGENEIC BONE-MARROW TRANSPLANTATION VS FILGRASTIM-MOBILIZED PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN PATIENTS WITH EARLY LEUKEMIA - FIRST RESULTS OF A RANDOMIZED MULTICENTER TRIAL OF THE EUROPEANGROUP FOR BLOOD AND MARROW TRANSPLANTATION

      Bone marrow transplantation
    92. VARADI G; ACKERSTEIN A; BENNERIAH S; NAGLER A
      ADOPTIVE CELL-MEDIATED IMMUNOTHERAPY WITH INTERLEUKIN-2 (IL-2) FOR RELAPSING LYMPHOBLASTIC CRISIS FOLLOWING MISMATCHED UNRELATED BONE-MARROW TRANSPLANTATION IN A CHRONIC MYELOGENOUS LEUKEMIA PATIENT

      Bone marrow transplantation
    93. ROCHA V; CHASTANG C; SOUILLET G; PASQUINI R; PLOUVIER E; NAGLER A; LOCATELLI F; SAARINEN U; CORNU G; BERNAUDIN F; GLUCKMAN E
      RELATED CORD-BLOOD TRANSPLANTS - THE EUROCORD EXPERIENCE FROM 78 TRANSPLANTS

      Bone marrow transplantation
    94. MINIERO R; ROCHA V; SARACCO P; LOCATELLI F; BRICHARD B; NAGLER A; ROBERTS I; YANIV I; BEKSAC M; BERNAUDIN F; GLUCKMAN E
      CORD-BLOOD TRANSPLANTATION (CBT) IN HEMOGLOBINOPATHIES

      Bone marrow transplantation
    95. MINIERO R; ROCHA V; SARACCO P; LOCATELLI F; NAGLER A; ROBERTS I; YANIV I; BEKSAC M; GLUCKMAN E
      CORD-BLOOD TRANSPLANTATION (CBT) IN HOMOZYGOUS B-THALASSEMIA (H-BETA-TH)

      Bone marrow transplantation
    96. NAGLER A; STOCKHEIM D; ELCHALAL U
      HARVESTING OF HUMAN UMBILICAL-CORD BLOOD (HUCB) BY VARIOUS METHODS

      Bone marrow transplantation
    97. SLAVIN S; NAGLER A; NAPARSTEK E; ACKERSTEIN A; KAPELUSHNIK Y; VARADI G; ALLAYAN H; KIRSCHBAUM M; BENYOSEF R; SAMUEL S
      ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION FOLLOWING NON-MYELOABLATIVE CONDITIONING FOR THE TREATMENT OF MALIGNANT AND NONMALIGNANT DISEASES

      Bone marrow transplantation
    98. NAGLER A; NAPARSTEK E; OR R; VARADI G; SLAVIN S
      THIOTEPA, BUSULFAN, CYCLOPHOSPHAMIDE AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR ACUTE-LEUKEMIA

      Bone marrow transplantation
    99. TOREN A; NAGLER A; NEUMANN Y; KAPLINSKY C; GOLAN H; MANDEL M; KENET G; SHARON N; AMARIGLIO N; BROKSIMONI F; BINIAMINOV M; LEVANON M; DAVIDSON J; RECHAVI G
      CORD-BLOOD STEM-CELL TRANSPLANTATION WITHOUT CONDITIONING IN SEVERE COMBINED IMMUNE-DEFICIENCY

      Bone marrow transplantation
    100. ENGELHARD D; OR R; STRAUSS N; ELISHOOV H; NAPARSTEK E; AKER M; CIVIDALLI G; NAGLER A; KAPELUSHNIK Y; SIMHON A; SHAPIRO M; MAAYAN S; RAHAV G; MOSES AE; SLAVIN S
      RISK-FACTORS FOR NOSOCOMIAL SEPTICEMIA FOLLOWING BONE-MARROW TRANSPLANTATION

      Bone marrow transplantation


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 11:37:50